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• We show that Chinese women have higher AMH levels than the European 
counterparts before age of 25, but after the age of 25 this is reversed and 
Chinese women have lower AMH levels. 




Objective: Chinese women are known to have an earlier age at natural menopause 
than their European counterparts, whether they also have a lower functional ovarian 
reserve is unknown. This study was designed to assess whether there are ethnic 
differences in Anti-Müllerian Hormone (AMH) in women of reproductive age. 
Materials and Methods: Women with regular menstrual cycles, not on hormonal 
contraception or with any medical history of note, were recruited to provide a day 2-5 
early follicular sample in China and Europe. AMH was determined using the Roche 
Elecsys assay. AMH decline was modelled with a linear, quadratic and quadratic 
with interaction on age equations to assess the impact of ethnicity.  
Results: 887 European and 461 Chinese women participated in the study. Despite 
the Chinese population being slightly younger 34.1±8.4 years than their European 
counterparts 34.8±8.9 years, their median AMH was lower 1.87 (IQR 0.28, 3.64) as 
compared to 2.11 (IQR 0.73, 3.96), with evidence of increasing discordance from 
age 25 years.  In all regression models of the AMH age–related decline, there was 
evidence of a difference between Chinese and European women. Whilst AMH was 
28.1% (95% CI; 18.2, 36.7%) lower in the Chinese population at age 30, this decline 
increased to 79.4% (95% CI; 75.4, 82.9%) at age 45. 
Conclusions: There were independent effects of age and ethnicity on serum AMH 
concentrations, with Chinese women having a substantially lower AMH in adult life 
than their European counterparts from age 25 onwards. 
 






The impact of ethnicity on sentinel reproductive events is increasingly recognised, 
with studies assessing the genetic architecture of reproductive aging identifying 
differences in allele frequency and effect estimates between European and Asian 
populations (Horikoshi, et al., 2018). The clinical impact of these differences may be 
substantial with the mean age at natural menopause being 1-2 years earlier in 
women of women of Chinese origin (Dorjgochoo, et al., 2008, Li, et al., 2012, Wang, 
et al., 2018), as compared to European populations (Cassou, et al., 2007, Hardy and 
Kuh, 2005, Parazzini, 2007).  At earlier ages, ethnic differences in assisted 
conception outcomes have also been observed, with lower live-birth rates for non-
European ethnicities, despite being treated in the same clinical setting (Dhillon, et al., 
2015, Maalouf, et al., 2017). The mechanism underlying these observations is not 
clear, as differences in ovarian response and the functional ovarian reserve have 
been observed in some (Bleil, et al., 2014, Purcell, et al., 2007, Seifer, et al., 2009) 
but not all studies (Bhide, et al., 2015, Iglesias, et al., 2014, Olcha, et al., 2016, 
Randolph Jr, et al., 2003).  
 
Several of these studies exploring ethnic differences, have primarily focused on 
patients attending infertility or medical clinics which may bias results, and attenuate 
differences due to the variable composition of underlying infertility diagnoses or the 
impact of disease on AMH concentrations (Bhide, et al., 2015, Olcha, et al., 2016, 
Purcell, et al., 2007). Infertility populations are also known to not be representative of 
the general population, as advanced ovarian aging is known to be overrepresented 
in infertile or diseased populations (Iliodromiti, et al., 2016). Existing studies  have 
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also been dependent on self-reported ethnicity which may be less accurate and 
subject to reporting bias (Sucheston, et al., 2012). Despite these limitations, analysis 
of anti-müllerian hormone (AMH), a marker of the functional ovarian reserve, has 
been reported to be lower in women of black or Hispanic ethnicity (Bleil, et al., 2014, 
Seifer, et al., 2009), and also of Chinese origin (Bleil, et al., 2014) in some but not all 
studies (Olcha, et al., 2016). Although suggestive of ethnic differences in the 
functional ovarian reserve (Bleil, et al., 2014, Seifer, et al., 2009), these studies used 
the older AMH assays, that are known to have substantial variability, particularly 
when used on samples stored for variable time period,  and required the use of  
conversion factors to be able to amalgamate the results over time (Iliodromiti, et al., 
2014, Nelson, et al., 2014).   
 
The aim of the current study was to determine whether there were ethnic differences 
in serum AMH concentrations using a current automated laboratory assay in 
contemporary non-select adult women from Europe and China. 
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Materials and Methods 
Study Participants 
Women from a European population living in the Netherlands, Belgium, Germany, 
France, Turkey and a Chinese population living in Beijing, were included. All 
participants were between 20 and 50 years of age. European women were recruited 
to a multicentre study to evaluate the analytical performance of the Elecsys® AMH 
assay and to facilitate determination of a reference range (Anckaert, et al., 2016). 
European participants were self-reported as apparently healthy, with a regular 
menstrual cycle (length 21–35 days). Women with a BMI exceeding 30 and/or 
receiving hormone replacement therapy or using hormonal contraceptives in the 
preceding 3 months were excluded from the study. Furthermore, women with 
infertility, gonadal disorder/dysfunction, diagnosed endometriosis, known previous or 
current endocrine or metabolic disorders were excluded. Chinese women were 
recruited in 8 communities in Beijing and had a regular menstrual cycles (24-35 
days) for the previous 3 months, had not taken oral contraceptives or any drug 
containing hormones within the past 3 months, had no history of ovarian surgery, 
and were required to provide a health report within 1 year confirming no concurrent 
comorbidities. Women with a history of polycystic ovary syndrome (PCOS), 
endocrine or metabolic abnormalities (i.e., diabetes, pituitary, adrenal, pancreas, 
liver, or kidney disturbances), current or past smokers were excluded. Early follicular 
serum samples were collected on day 2-5 for all participants. 
 
All investigation and sample collection sites followed International Conference on 
Harmonization guideline for Good Clinical Practice E6 and conducted the study in 
accordance with the Declaration of Helsinki (as amended in Tokyo, Venice, Hong 
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Kong, and Edinburgh). Where required, Ethics Committee approval of the respective 
institutions was obtained. Specifically; ethical approval for the European cohort is on 
file at Roche Switzerland and was obtained from the following institutions; UZ 
Brussels, Free University of Brussels (VUB), Belgium; Duzen Laboratories, Ankara, 
Turkey; Laboratoire Eylau, Paris, France; Limbach Laboratory, Heidelberg and MVZ 
wagnerstibbe für Laboratoriumsmedizin and Pathologie GmbH, Hannover, Germany. 
Ethical approval for the Chinese cohort was obtained from the Peking Union Medical 
College Hospital.  
 
Sample measurements 
Three ml serum aliquots for each participant were stored at −80°C. AMH was 
measured on first thaw of stored samples using the Elecsys® AMH automated 
method on a clinically validated platform (cobas e 411, e 601 and E 170 Roche 
Diagnostics, Germany)(Anckaert, et al., 2016). The assay was calibrated and quality 
controlled using the manufacturer's reagents. All AMH samples from the European 
and Chinese population were measured in the respective laboratories (Peking Union 
Medical College Hospital and Laboratory of Hormonology and Tumour Markers, 
Universitair Ziekenhuis Brussel) using the same AMH assay. The within-run 
imprecision was investigated by the study sponsor providing each laboratory with 
spiked serum sample material in five levels covering the entire measuring interval. 
Each sample level was analysed 21 times in one analytical run. Mean, standard 
deviation and the coefficient of variation (CV) were calculated from these data. The 
repeatability and intermediate imprecision were investigated using two levels of 
quality control material (Elecsys® PreciControl AMH 1 and 2 assay, Roche 
Diagnostics GmbH, Germany) and the same five levels of spiked serum pool 
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material covering the lower and upper measuring interval. The spiked serum material 
was provided to the sites in frozen aliquots. 
  
Across the range of 0.24ng/ml (1.71pmol/l) to 19.17ng/ml (136pmol/l) the within-run 
imprecision was 0.7 to 3.4%, the repeatability CVs ranged from 1.2 to 1.7% and the 
intermediate CVs ranged from 2.2% to 4.4%. The limit of quantitation (LoQ) was 
0.03 ng/ml. All values between the two sites can therefore be compared uniformly. 
 
Statistical analyses 
AMH was compared between the two ethnicity groups using linear regression. As may 
be expected the distribution of AMH in each ethnicity group follows a right skewed 
distribution reflecting that a few women have high values whilst the majority of women 
have lower values, with some closer to zero. We therefore present the median and 
IQR of the untransformed data in the descriptive tables and model the (natural) log 
transformed AMH data. Differences between the ethnicity groups and confidence 
intervals were calculated on the log-scale. These values were then back-transformed 
and are interpreted as the ratio of geometric means (GM/GMR). Graphs displayed are 
in original units and values were derived by back transforming from the log scale. 
 
Age and ethnicity were included in each of the models and the European group used 
as the reference group. Age was also be centered to avoid interpretation at age 0.  
Quadratic age (or other powers) were included if they improved model fit (using 
likelihood ratio tests). If an age x ethnicity interaction term was present, then separate 
ethnicity effect estimates at appropriate age categories are presented. If the interaction 
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was not statistically significant (at 10% level) an overall difference in ethnicity is 
reported.  
  
Model fit was assessed via standard methods (e.g. graphical plots). This included 
checking the relationship between the observed and predicted values was linear, 
checking there was constant variance between the predicted values and residuals and 
that the residuals were normally distributed. The R2 statistic, the proportion of variation 
explained by the model, was also reported. A sensitivity analysis was conducted to 
assess the impact of values less than the LoQ by uniformly imputing values from 
between a fixed lower value of 0.01 ng/ml and the LoQ of 0.03 ng/ml. Analyses were 





A total of 1348 subjects met the inclusion criteria and participated in the study; 887 
European and 461 Chinese women. Despite the Chinese population being slightly 
younger 34.1 ± 8.4 years than their European counterparts 34.8 ± 8.9 years, their 
median AMH was lower 1.87 (IQR 0.28, 3.64) as compared to 2.11 (IQR 0.73, 3.96). 
These differences were apparent at each age group (Table 1).  
 
Of the three models fitted, the model with a quadratic age term and an interaction 
term between age and ethnicity explained the most variability in AMH (R-
squared=67.75) In all regression models of the AMH age–related decline, there was 
evidence of a difference in AMH by ethnicity (lower values in Chinese women; Table 
2).There was evidence of an ethnicity age interaction and therefore separate 
ethnicity effects are presented for each age group (Table 3). Despite a slightly higher 
AMH value at age 20, overall lower AMH levels were found in the Chinese 
population compared to the European population: at age 30 AMH was 28.1% (95% 
CI, 18.2 to 36.7%) lower; at age 35 AMH was 52.6% (95% CI, 46.9 to 57.8%) lower; 
at age 40 AMH was 68.8% (95% CI, 64.2 to 72.8%) lower; at age 45 AMH was 
79.4% (95% CI, 75.4 to 82.9%) lower and at age 50 AMH was 86.5% (95% CI, 82.8 
to 89.4%) lower.  
 
To further assess the impact of ethnicity on AMH we plotted the actual values and 
modelled the GM of AMH for any given age using the best model which incorporated 
a quadratic term of log(AMH) on age with ethnicity and interaction between age and 
ethnicity is shown in Figure 1. This model was then used to display the predicted log 
AMH and associated 95% CI, which clearly shows that the Chinese population 
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despite a similar starting point, exhibited a faster decline in functional ovarian 






In this large cohort of healthy adult Chinese and European women, we demonstrate 
that Chinese women initially exhibit higher circulating serum AMH concentrations 
than their European counterparts. However, after age 25 this pattern was reversed, 
with Chinese women exhibiting substantially lower AMH, and the apparent disparity 
widening with advancing age.  These findings are consistent with previous smaller 
analyses of infertile or medical patient populations (Bleil, et al., 2014, Seifer, et al., 
2009), and support epidemiological observations that Chinese adult women exhibit 
an accelerated age-related decline in their ovarian reserve and an earlier age at 
natural menopause (Cassou, et al., 2007, Dorjgochoo, et al., 2008, Hardy and Kuh, 
2005, Li, et al., 2012, Parazzini, 2007, Wang, et al., 2018).  
 
Previous studies, have suggested that there are racial disparities in ovarian reserve, 
despite a similar age at menarche, with Chinese women have an age at natural 
menopause that is 1- 2 years younger than Europeans (Cassou, et al., 2007, 
Dorjgochoo, et al., 2008, Hardy and Kuh, 2005, Li, et al., 2012, Parazzini, 2007, 
Wang, et al., 2018).  Although AMH is principally recognised as a biomarker of the 
functional ovarian reserve, and is primarily used to predict ovarian response to 
gonadotrophin stimulation (Iliodromiti, et al., 2014), it has been shown to be strongly 
correlated with primordial follicle counts(Hansen, et al., 2011). That menopause 
represent a terminal depletion of primordial follicles (Depmann, et al., 2015), the 
earlier age of menopause in Chinese women would be consistent with our observed 
premature decline in AMH in this population. Determining whether this excessive 
drop in AMH in adulthood reflects fewer follicles at birth or excessive follicular 
recruitment prepubertally and therefore fewer follicles in later life (Kelsey, et al., 
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2012), is limited by our cross-sectional design. However, in support of the former, is 
our observation that the AMH peak at age 25 years is very similar for the two 
ethnicities, with 25 years previously noted to be the peak plateau of AMH across the 
lifespan (Kelsey, et al., 2011). The ability of the ovary to manage follicular 
recruitment rates in adult life, depending on the number of follicles available, is also 
supported by the observation that unilateral oophorectomy also only reduces the age 
at natural menopause by 1-2 years (Rosendahl, et al., 2017).  
 
The observation that AMH was higher at age 20 and then lower throughout the adult 
lifespan in Chinese women is interesting. We have previously shown that AMH 
levels, reflect follicular recruitment levels throughout life (Fleming, et al., 2012), rise 
to a maximum at age 25 and then decline thereafter(Kelsey, et al., 2011). At present 
it not however known whether an excessive follicular recruitment and thereby higher 
AMH in adolescent and early adult life is detrimental to the overall reproductive 
lifespan. Longitudinal prospective studies with repeat measures in diverse ethnic 
populations will be helpful in determining whether women with increased AMH in 
childhood or adolescence have impaired ovarian reserve and a shorter time to 
menopause. 
 
There has been considerable interest in whether ethnic specific reference ranges 
should be determined for ovarian biomarkers (Du, et al., 2016, Lee, et al., 2017). 
There is however, no evidence that ethnicity modifies the association between 
circulating AMH concentrations and ovarian response, with recent multicentre trials 
reporting similar strengths of association irrespective of ethnicity (Nyboe Andersen, 
et al., 2016). The role of reporting an ethnic specific reference range would therefore 
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be more useful if there was agreement that AMH could be used for counselling 
regarding the reproductive lifespan particularly given the earlier age at natural 
menopause in Chinese populations (Cassou, et al., 2007, Dorjgochoo, et al., 2008, 
Hardy and Kuh, 2005, Li, et al., 2012, Parazzini, 2007, Wang, et al., 2018). However, 
although lower age-specific AMH is associated with an increased risk of premature 
ovarian insufficiency(Bertone-Johnson, et al., 2018), wider application for counselling 
regarding reproductive status and future fertility potential has been criticised by 
professional bodies (Opinion, 2019). It may therefore be detrimental to report ethnic 
specific reference ranges, particularly if patients were not aware of the overall 
shorter reproductive lifespan and earlier age at natural menopause, as they may be 
falsely reassured by being placed on the equivalent centile but at a much lower 
actual value than their European counterparts.  
 
Although our study has a number of strengths including its large sample size 
inclusion of healthy women not on any form of contraception or with medical 
disorders, timed early follicular sampling and robust statistical analysis we do 
acknowledge a number of limitations. Firstly the AMH samples although similarly 
collected were processed in different laboratories. However, both laboratories in 
Europe and China were part of ongoing regulatory quality control processes, with 
cross-measurement of control samples provided by Roche, and the Elecsys AMH 
assay has previously been shown to be robust across different scale of machines 
and sites with an overall inter-laboratory CV of <10%, the observed differences 
clearly exceed this (Anckaert, et al., 2016). The increased performance, reliability 
and sensitivities of the automated AMH assay platforms over previous manual ELSIA 
iterations have also been well documented (Iliodromiti, et al., 2014, Nelson, et al., 
14 
 
2014).  Secondly, we did not have details on other potential determinants of AMH 
concentrations such as smoking in the European population, with smoking known to 
deplete antral follicles and thereby AMH (Freour, et al., 2008). However, smoking is 
substantially more prevalent in European women of reproductive age than their 
Chinese counterparts (Hermalin and Lowry, 2010), and as such any discordance in 
smoking behaviour would only attenuate the observed ethnic differences. Similarly 
we did not have information on adiposity, but previous large studies (de Kat, et al., 
2016) including those with DXA determined fat mass (Anderson, et al., 2013), have 
not shown an impact of BMI on AMH concentrations.  We also did not have 
information on socioeconomic class, such that if there was a systematic discordance 
in socioeconomic status between the two populations this may have contributed to 
the observed differences, as lower socioeconomic class has been associated with 
lower AMH levels (Barut, et al., 2016).  Thirdly, our study was cross-sectional in 
design, which precludes the examination of trajectories of the decline in AMH, 
although our limited extrapolation of the decline in AMH is consistent with 
longitudinal studies with repeat measures. Lastly, we are unable to dissect whether 
these observed discordances are solely due to ethnicity or due to living in quite 
different settings with different environment, lifestyles, early life exposures or other 
potential confounders. Further well powered studies examining healthy unselected 
participants resident in a similar setting with unified inclusion criteria would begin to 
address some of these issues.  
 
In conclusion, our study suggests that in healthy premenopausal women, there are 
substantial racial/ethnic difference in the functional ovarian reserve as determined by 
AMH. Such that Chinese women resident in China have significantly lower AMH 
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concentrations, and potentially ovarian reserve compared to their European 
counterparts consistent with their known earlier age at natural menopause. 
Development of racial/ethnic specific AMH reference ranges should be made with 
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Overall (Mean, SD)   2.69 2.45   2.38 2.40 
Overall (Median, IQR)   2.11 (0.73, 3.96)   1.87 (0.28, 3.64) 
Overall years (Range)    (0.01, 15.73)    (0.01, 11.69) 
20-24 years (Mean, SD) 150/887 16.9% 4.62 2.61 63/461 13.7% 5.68 2.33 
20-24 years (Median, IQR)   4.00 (2.87, 6.01)   5.84 (3.80, 7.12) 
20-24 years (Range)    (0.48, 15.73)    (1.32, 11.69) 
25-29 years (Mean, SD) 150/887 16.9% 4.05 2.29 107/461 23.2% 3.54 1.56 
25-29 years (Median, IQR)   3.31 (2.40, 5.39)   3.31 (2.48, 3.94) 
25-29 years (Range)    (0.49, 11.34)    (0.81, 9.66) 
30-34 years (Mean, SD) 138/887 15.6% 3.39 2.10 79/461 17.1% 2.86 2.12 
30-34 years (Median, IQR)   2.80 (1.57, 4.72)   2.10 (1.40, 3.86) 
30-34 years (Range)    (0.26, 9.72)    (0.66, 10.30) 
35-39 years (Mean, SD) 138/887 15.6% 2.55 2.03 78/461 16.9% 1.22 1.22 
35-39 years (Median, IQR)   2.00 (1.14, 3.55)   0.82 (0.37, 1.59) 
35-39 years (Range)    (0.05, 10.91)    (0.10, 5.72) 
40-44 years (Mean, SD) 142/887 16.0% 1.32 1.34 64/461 13.9% 0.44 0.63 
40-44 years (Median, IQR)   0.88 (0.32, 1.83)   0.13 (0.04, 0.65) 
40-44 years (Range)    (0.01, 6.76)    (0.02, 2.58) 
45-50 years (Mean, SD) 169/887 19.1% 0.47 0.69 70/461 15.2% 0.13 0.35 
45-50 years (Median, IQR)   0.19 (0.06, 0.59)   0.01 (0.01, 0.01) 
45-50 years (Range)    (0.01, 4.16)    (0.01, 2.60) 
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Table 2: Regression models describing the decline in AMH with age and impact of ethnicity 
 
Model Algebraic form Parameter GMR (95% CI) 𝑹𝟐 
Linear (1) ln(𝐴𝑀𝐻) = 𝑎 + 𝑏𝐴𝑔𝑒 + 𝑐𝐸𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦* 𝑎 1.394 (1.291, 1.506)  
  𝑏 0.859 (0.853, 0.866) 56.85 
  𝑐 0.531 (0.466, 0.606)  
Quadratic (2) ln(𝐴𝑀𝐻) = 𝑎 + 𝑏𝐴𝑔𝑒 + 𝑐𝐸𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦 + 𝑑𝐴𝑔𝑒2 𝑎 2.463 (2.234, 2.715)  
  𝑏 0.864 (0.858, 0.870) 64.15 
  𝑐 0.502 (0.445, 0.566)  




 𝑎 2.401 (2.188, 2.633)  
ln(𝐴𝑀𝐻) = 𝑎 + 𝑏𝐴𝑔𝑒 + 𝑐𝐸𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦 + 𝑑𝐴𝑔𝑒2 + 𝑒𝐴𝑔𝑒𝐸𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦 𝑏 0.887 (0.880, 0.894)  
 𝑐 0.493 (0.440, 0.553) 67.75 
 𝑑 0.993 (0.992, 0.994)  
 𝑒 0.920 (0.908, 0.932)  





Table 3 Geometric mean ratio of AMH by age band and effect of ethnicity 
 
Age Ethnicity Geometric mean Geometric mean ratio (95% CI) 
20 European 3.13 (2.63, 3.72) 
1.66 (1.33, 2.07) 
 Chinese 5.19 (4.16, 6.48) 
25 European 3.99 (3.61, 4.40) 
1.09 (0.92, 1.29) 
 Chinese 4.35 (3.79, 5.00) 
30 European 3.58 (3.27, 3.91) 
0.72 (0.63, 0.82) 
 Chinese 2.57 (2.31, 2.87) 
35 European 2.26 (2.06, 2.48) 
0.47 (0.42, 0.53) 
 Chinese 1.07 (0.96, 1.20) 
40 European 1.01 (0.92, 1.10) 
0.31 (0.27, 0.36) 
 Chinese 0.31 (0.28, 0.35) 
45 European 0.32 (0.29, 0.35) 
0.21 (0.17, 0.25) 
 Chinese 0.06 (0.06, 0.08) 
50 European 0.07 (0.06, 0.08) 
0.14 (0.11, 0.17) 
 Chinese 0.01 (0.01, 0.01) 
 
Differences between the ethnicity groups and confidence intervals were calculated on the log-scale. These values were then back-transformed 




Figure 1 Geometric mean with 95% CI by ethnicity group (orange=Chinese, green=European) , 








Figure 2 Predicted log(AMH), based on a quadratic model of log(AMH) on age with ethnicity and an 
interaction between age and ethnicity. Shown is the predicted logAMH value versus age, with 95% CI 
and PI. 
 
 
